Publications by authors named "Yogiraj Ray"

Claim this Profile
T
Transient Pure Red Cell Aplasia in a Case of Plasmodium falciparum and Parvovirus B19 Coinfection.
Christy Varghese John, Ayan Basu, Debdas Bose, Yogiraj Ray

Am J Trop Med Hyg· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Temporal TCR dynamics and epitope diversity mark recovery in severe COVID-19 patients.
Kriti Khare, Sunita Yadav, Sayanti Halder, Yogiraj Ray, Dipyaman Ganguly

Front Immunol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Strongyloides stercoralis hyperinfection syndrome.
Lemna Jacob, Ayan Basu, Dipankar Paul, Yogiraj Ray, Nazneen Nahar Begam

Lancet Infect Dis· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cervicofacial Actinomycetoma Presenting with Black Grain: A Rare Clinical Scenario.
Shubham Lodha, Suman Biswas, Ayan Basu, Nupur Pal, Bikram Das, Yogiraj Ray

J Assoc Physicians India· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Suppressed transcript diversity and immune response in COVID-19 ICU patients: a longitudinal study.
Priyanka Mehta, Partha Chattopadhyay, Ramakant Mohite, Ranit D'Rozario, Purbita Bandopadhyay, Yogiraj Ray

Life Sci Alliance· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Post COVID sequelae among COVID-19 survivors: insights from the Indian National Clinical Registry for COVID-19.
Gunjan Kumar, Ashish Bhalla, Aparna Mukherjee, Alka Turuk, Arunansu Talukdar, Yogiraj Ray

BMJ Glob Health· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of gut microbial dysbiosis with disease severity, response to therapy and disease outcomes in Indian patients with COVID-19.
Daizee Talukdar, Purbita Bandopadhyay, Yogiraj Ray, Shekhar Ranjan Paul, Jafar Sarif

Gut Pathog· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating Interleukin-8 Dynamics Parallels Disease Course and Is Linked to Clinical Outcomes in Severe COVID-19.
Ranit D'Rozario, Deblina Raychaudhuri, Purbita Bandopadhyay, Jafar Sarif, Priyanka Mehta, Yogiraj Ray

Viruses· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Trial Subgroup Analyses to Investigate Clinical and Immunological Outcomes of Convalescent Plasma Therapy in Severe COVID-19.
Deblina Raychaudhuri, Purbita Bandopadhyay, Ranit D'Rozario, Jafar Sarif, Yogiraj Ray

Mayo Clin Proc Innov Qual Outcomes· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 2 single center open label randomised control trial for convalescent plasma therapy in patients with severe COVID-19.
Yogiraj Ray, Shekhar Ranjan Paul, Purbita Bandopadhyay, Ranit D'Rozario, Jafar Sarif, Deblina Raychaudhuri

Nat Commun· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and Validation of a Treatment Benefit Index to Identify Hospitalized Patients With COVID-19 Who May Benefit From Convalescent Plasma.
Hyung Park, Thaddeus Tarpey, Mengling Liu, Keith Goldfeld, Yinxiang Wu, Yogiraj Ray

JAMA Netw Open· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A prospective study on COVID-19 convalescent plasma donor (CCP) recruitment strategies in a resource constrained blood centre.
Durba Biswas, Chikam Maiti, Biplabendu Talukder, Md Azharuddin, Sayantan Saha, Yogiraj Ray

ISBT Sci Ser· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasma Gradient of Soluble Urokinase-Type Plasminogen Activator Receptor Is Linked to Pathogenic Plasma Proteome and Immune Transcriptome and Stratifies Outcomes in Severe COVID-19.
Jafar Sarif, Deblina Raychaudhuri, Ranit D'Rozario, Purbita Bandopadhyay, Praveen Singh, Yogiraj Ray

Front Immunol· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nature and Dimensions of Systemic Hyperinflammation and its Attenuation by Convalescent Plasma in Severe COVID-19.
Purbita Bandopadhyay, Ranit D'Rozario, Abhishake Lahiri, Jafar Sarif, Yogiraj Ray

J Infect Dis· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Isolation, characterization and acyclovir susceptibility of herpes simplex virus isolates among immunocompromised patients.
Soumyabrata Nag, Mallika Sengupta, Soma Sarkar, Yogiraj Ray, Debprasad Chattopadhyay

Indian J Sex Transm Dis AIDS· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Collateral damage due to COVID-19.
Farhan Fazal, Nitin Gupta, Wasim Khot, Yogiraj Ray

Trop Doct· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk Benefit Analysis in Reference to use of LMWH in COVID-19.
Shambo Samrat Samajdar, Priya Ann Sam, Saibal Moitra, Yogiraj Ray, Jyotirmoy Pal

J Assoc Physicians India· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Choosing the therapy for neurological infection with rapidly growing mycobacteria.
Atman Dash, Nitin Gupta, Yogiraj Ray, Parul Kodan, Binit Kumar Singh

Drug Discov Ther· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of trainee-driven Antimicrobial Stewardship Program in a high burden resource-limited setting.
Sayantan Banerjee, Nitin Gupta, Yogiraj Ray, Parul Kodan, Wasim Yunus Khot

Infez Med· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Brain abscess in patients with chronic kidney disease: A case-based approach to management in resource-limited settings.
Nitin Gupta, Rohit Kumar, Sayantan Banerjee, Gagandeep Singh, Sundeep Malla, Yogiraj Ray

Drug Discov Ther· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nontuberculous mycobacteria: A report of eighteen cases from a tertiary care center in India.
Nitin Gupta, Ankit Mittal, Vettakkara Kandy Muhammed Niyas, Sayantan Banerjee, Yogiraj Ray

Lung India· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nipah virus disease: A rare and intractable disease.
Sayantan Banerjee, Nitin Gupta, Parul Kodan, Ankit Mittal, Yogiraj Ray

Intractable Rare Dis Res· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nosocomial pneumonia: Search for an empiric and effective antibiotic regimen in high burden tertiary care centre.
Nitin Gupta, Manish Soneja, Yogiraj Ray, Monalisa Sahu, Kutty Sharada Vinod

Drug Discov Ther· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SLE in a Male Patient Presented Initially as Rowell's Syndrome.
Ayan Basu, Yogiraj Ray, Pratik Bhowmik, Mehebubar Rahman, Rama Prosad Goswami

J Assoc Physicians India· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Scleroderma-like Initial Presentation of Multiple Myeloma.
Ayan Basu, Santanu Kundu, Mehebubar Rahman, Yogiraj Ray, Rama Prosad Goswami

J Assoc Physicians India· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis